Boothbay Fund Management’s ResMed RMD Stock Holding History

Boothbay Fund Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$476K	Buy	+2,444	New	+$507K	0.01%	1526
2024 Q1	–	Sell	-1,444	Closed	-$248K	–	1883
2023 Q4	$248K	Sell	1,444 -119	-8%	-$18.3K	0.01%	1264
2023 Q3	$231K	Sell	1,563 -504	-24%	-$91.1K	0.01%	1378
2023 Q2	$452K	Sell	2,067 -295	-12%	-$65.7K	0.01%	1154
2023 Q1	$517K	Sell	2,362 -326	-12%	-$70.7K	0.01%	1242
2022 Q4	$559K	Sell	2,688 -2,918	-52%	-$641K	0.01%	1131
2022 Q3	$1.22M	Buy	5,606 +2,667	+91%	+$607K	0.03%	782
2022 Q2	$616K	Sell	2,939 -53	-2%	-$11.3K	0.02%	1072
2022 Q1	$726K	Sell	2,992 -2,344	-44%	-$567K	0.02%	1097
2021 Q4	$1.39M	Buy	+5,336	New	+$1.38M	0.03%	619
2021 Q3	–	Sell	-3,080	Closed	-$759K	–	2144
2021 Q2	$759K	Sell	3,080 -17,885	-85%	-$3.76M	0.02%	816
2021 Q1	$4.07M	Buy	+20,965	New	+$4.2M	0.15%	136

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Boothbay Fund Management's RMD Position: Q2 2026 in Review

Boothbay Fund Management opened a new position in ResMed (RMD) in Q2 2026: 2,444 shares worth $476K. The stake represents 0.01% of the portfolio and ranks #1526 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in RMD as recently as Q4 2023.

Boothbay Fund Management first reported a position in RMD in Q1 2021 and has held it in 12 quarters since. The position peaked at $4.07M in Q1 2021. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Boothbay Fund Management held 2,444 shares of ResMed worth $476K as of Q2 2026.
ResMed was a new Boothbay Fund Management position in Q2 2026.
ResMed made up 0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #1526 holding.
Boothbay Fund Management first reported a position in ResMed in Q1 2021 and has held it in 12 quarters since.
Boothbay Fund Management's ResMed position peaked at $4.07M in Q1 2021.
891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.